| Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition M Vaccari, SN Gordon, S Fourati, L Schifanella, NPM Liyanage, ... Nature medicine 22 (7), 762-770, 2016 | 210 | 2016 |
| Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination S Fourati, R Cristescu, A Loboda, A Talla, A Filali, R Railkar, AK Schaeffer, ... Nature communications 7 (1), 10369, 2016 | 165 | 2016 |
| Mucosal effects of tenofovir 1% gel F Hladik, A Burgener, L Ballweber, R Gottardo, L Vojtech, S Fourati, ... Elife 4, e04525, 2015 | 66 | 2015 |
| HIV vaccine candidate activation of hypoxia and the inflammasome in CD14+ monocytes is associated with a decreased risk of SIVmac251 acquisition Nature Medicine, 2018 | 63 | 2018 |
| Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody M Asokan, J Dias, C Liu, A Maximova, K Ernste, A Pegu, K McKee, W Shi, ... Proceedings of the National Academy of Sciences 117 (31), 18754-18763, 2020 | 58 | 2020 |
| Single cell RNA sequencing of AML initiating cells reveals RNA-based evolution during disease progression LC Stetson, D Balasubramanian, SP Ribeiro, T Stefan, K Gupta, X Xu, ... Leukemia 35 (10), 2799-2812, 2021 | 49 | 2021 |
| Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccination S Fourati, LE Tomalin, MP Mulè, DG Chawla, B Gerritsen, D Rychkov, ... Nature Immunology 23 (12), 1777-1787, 2022 | 47 | 2022 |
| Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses T Hagan, B Gerritsen, LE Tomalin, S Fourati, MP Mulè, DG Chawla, ... Nature immunology 23 (12), 1788-1798, 2022 | 47 | 2022 |
| Translocated microbiome composition determines immunological outcome in treated HIV infection K Nganou-Makamdop, A Talla, AA Sharma, S Darko, A Ransier, ... Cell 184 (15), 3899-3914. e16, 2021 | 47 | 2021 |
| Integrated systems approach defines the antiviral pathways conferring protection by the RV144 HIV vaccine S Fourati, SP Ribeiro, F Blasco Tavares Pereira Lopes, A Talla, ... Nature communications 10 (1), 863, 2019 | 36 | 2019 |
| Transcriptional profiles reveal a stepwise developmental program of memory CD8+ T cell differentiation R Roychoudhuri, F Lefebvre, M Honda, L Pan, Y Ji, CA Klebanoff, ... Vaccine 33 (7), 914-923, 2015 | 34 | 2015 |
| Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study A Ozonoff, J Schaenman, ND Jayavelu, CE Milliren, CS Calfee, CB Cairns, ... EBioMedicine 83, 2022 | 32 | 2022 |
| The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccination JA Tomalka, AN Pelletier, S Fourati, MB Latif, A Sharma, K Furr, K Carlson, ... Nature immunology 22 (10), 1294-1305, 2021 | 23 | 2021 |
| The immune signatures data resource, a compendium of systems vaccinology datasets J Diray-Arce, HER Miller, E Henrich, B Gerritsen, MP Mulè, S Fourati, ... Scientific Data 9 (1), 635, 2022 | 16 | 2022 |
| Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacy F Barrenäs, SG Hansen, L Law, C Driscoll, RR Green, E Smith, J Chang, ... PLoS pathogens 17 (7), e1009278, 2021 | 16 | 2021 |
| A crowdsourced analysis to identify ab initio molecular signatures predictive of susceptibility to viral infection S Fourati, A Talla, M Mahmoudian, JG Burkhart, R Klén, R Henao, T Yu, ... Nature communications 9 (1), 4418, 2018 | 16 | 2018 |
| Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition G Gorini, S Fourati, M Vaccari, MA Rahman, SN Gordon, DR Brown, ... PLoS pathogens 16 (3), e1008377, 2020 | 15 | 2020 |
| Myeloid cell crosstalk regulates the efficacy of the DNA/ALVAC/gp120 HIV vaccine candidate M Vaccari, S Fourati, DR Brown, I Silva de Castro, M Bissa, L Schifanella, ... Frontiers in immunology 10, 1072, 2019 | 15 | 2019 |
| Monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as a potential mechanism of vaccine-induced protection against HIV-1 S Shangguan, PK Ehrenberg, A Geretz, L Yum, G Kundu, K May, ... Elife 10, e69577, 2021 | 14 | 2021 |
| Systems biology and the quest for correlates of protection to guide the development of an HIV vaccine L Kuri-Cervantes, S Fourati, G Canderan, RP Sekaly Current Opinion in Immunology 41, 91-97, 2016 | 13 | 2016 |
